Back to Search
EUGENIO CERSOSIMO MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1396756409Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
L4288(TX)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
NCT02981966COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
NCT02981069COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Molecular Mechanisms of Type 2 Diabetes Mellitus
NCT00816218COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
NCT00820573COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.
PMID 23579178·Diabetes Care·2013
2-rct
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.
PMID 19169664·Diabetologia·2009
2-rct
Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effects.
PMID 18983329·J Cardiometab Syndr·2008
4-observational
Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.
PMID 18633101·Diabetes·2008
8-other
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
PMID 18334612·Am J Physiol Endocrinol Metab·2008
8-other
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.
PMID 17909084·Diabetes Care·2008
2-rct
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone.
PMID 17244785·J Clin Endocrinol Metab·2007
2-rct
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
PMID 17299078·Am J Physiol Endocrinol Metab·2007
2-rct
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.
PMID 17327455·Diabetes·2007
3-trial
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus.
PMID 17361126·Clin Pharmacol Ther·2007
8-other
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
PMID 17681171·Gastroenterology·2007
4-observational
Comprehensive assessment of postischemic vascular reactivity in Hispanic children and adults with and without diabetes mellitus.
PMID 17212600·Pediatr Diabetes·2006
8-other
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
PMID 17065670·Diabetes Care·2006
3-trial
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.
PMID 15562199·Diabetes Care·2004
3-trial
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
PMID 14715850·J Clin Endocrinol Metab·2004
8-other
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
PMID 12765945·Diabetes·2003
8-other
Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes.
PMID 11522675·Diabetes·2001
3-trial
Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans.
PMID 10909977·Diabetes·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 701 S ZARZAMORA ST
SAN ANTONIO, TX 78207 - Phone
- (210) 358-7500
Quick Facts
- NPI
- 1396756409
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile